HI Form 4: Director Joy Greenway receives 368 restricted stock units

Rhea-AI Filing Summary

Joy M. Greenway, a director of Hillenbrand, Inc. (HI), was awarded a series of Restricted Stock Units on 09/30/2025. The Form 4 reports the acquisition of 368 RSUs across awards dated 2013–2025 (individual grant amounts: 21, 33, 33, 38, 27, 24, 24, 36, 25, 23, 24, 26, 34). Each RSU represents the right to one share and the awards carry dividend equivalent rights; the reported per-share price is $0 because these are compensation awards rather than market purchases.

The filing notes vesting rules: some older awards vest immediately but have post-service holding requirements, while more recent awards vest at the next annual meeting or one year from grant and include accelerated vesting on a change in control, death, or disability. The Form 4 was filed by an attorney-in-fact on behalf of Ms. Greenway and shows these transactions were reported as acquisitions of derivative securities that convert into common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Greenway Joy M

(Last) (First) (Middle)

ONE BATESVILLE BOULEVARD

(Street)

BATESVILLE IN 47006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hillenbrand, Inc. [ HI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Deferred Stock Award 2/27/13)	(1)	09/30/2025		A(2)		21		(3)	(3)	Common Stock	21	$0	2,662	D
Restricted Stock Units (Deferred Stock Award 2/26/14)	(1)	09/30/2025		A(2)		33		(3)	(3)	Common Stock	33	$0	4,176	D
Restricted Stock Units (Deferred Stock Award 2/25/15)	(1)	09/30/2025		A(2)		33		(3)	(3)	Common Stock	33	$0	4,126	D
Restricted Stock Units (Deferred Stock Award 2/24/16)	(1)	09/30/2025		A(2)		38		(3)	(3)	Common Stock	38	$0	4,696	D
Restricted Stock Units (Deferred Stock Award 2/22/17)	(1)	09/30/2025		A(2)		27		(3)	(3)	Common Stock	27	$0	3,319	D
Restricted Stock Units (Deferred Stock Award 2/15/18)	(1)	09/30/2025		A(2)		24		(3)	(3)	Common Stock	24	$0	2,933	D
Restricted Stock Units (Deferred Stock Award 2/14/19)	(1)	09/30/2025		A(2)		24		(3)	(3)	Common Stock	24	$0	2,942	D
Restricted Stock Units (Deferred Stock Award 2/13/20)	(1)	09/30/2025		A(2)		36		(3)	(3)	Common Stock	36	$0	4,400	D
Restricted Stock Units (Deferred Stock Award 2/11/21)	(1)	09/30/2025		A(2)		25		(4)	(4)	Common Stock	25	$0	3,099	D
Restricted Stock Units (Deferred Stock Award 2/10/22)	(1)	09/30/2025		A(2)		23		(4)	(4)	Common Stock	23	$0	2,862	D
Restricted Stock Units (Deferred Stock Award 2/24/23)	(1)	09/30/2025		A(2)		24		(4)	(4)	Common Stock	24	$0	2,913	D
Restricted Stock Units (Deferred Stock Award 2/20/24)	(1)	09/30/2025		A(2)		26		(4)	(4)	Common Stock	26	$0	3,165	D
Restricted Stock Units (Deferred Stock Award 2/18/25)	(1)	09/30/2025		A(2)		34		(4)	(4)	Common Stock	34	$0	4,122	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.

2. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.

3. These Restricted Stock Units vest immediately upon grant. However, for awards granted prior to May 2014, directors must hold the underlying shares of common stock of the Company for six months after they cease serving as a director, and for awards granted in May 2014 or later, directors must hold the underlying shares of common stock of the Company for one day after the director ceases serving.

4. These Restricted Stock Units vest on the earlier to occur of the issuer's next annual meeting of shareholders or one year from the date of grant; provided, that these Restricted Stock Units will immediately vest upon, and in any case delivery of the shares underlying these Restricted Stock Units will not occur until, the occurrence of one of the following: a change in control of the issuer, the director's death or permanent and total disability, or one day after the date the director ceases to be a director of the issuer

Remarks:

	/s/ Allison A. Westfall, Attorney-in-Fact for Joy M. Greenway	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.